OUTCOME OF TRANSURETHRAL RESECTION OF PROSTATE IN CLINICAL BENIGN PROSTATIC HYPERPLASIA

Authors

  • HR Bozdar
  • SR Memon
  • JP Paryani

Abstract

Background: Benign prostatic hyperplasia (BPH) is a condition in which the prostate gland becomesenlarged. Some men with enlarged prostate glands may experience symptoms while some may havefew symptoms. Symptomatic improvement determines the successful outcome of surgical procedure ofTURP for clinical BPH patients. Objectives of this study were to assess the outcome of transurethralresection of prostate (TURP) in clinical BPH with the help of International Prostate Symptom Score(IPSS). Methods: This was descriptive case series study conducted at the Department of Urology,Liaquat University of Medical and Health Sciences, Jamshoro from November 2009 to April 2010. Allpatients who underwent TURP for clinical BPH were included in the study. Their preoperative IPSSwas done by asking irritative and obstructive symptoms. IPSS was calculated for patients whopresented with urinary retention by asking lower urinary tract symptoms before urinary retention. Eachsymptom carried a score of 0–5, and the total score was 35. After the TURP, IPSS was calculated on 1stfollow-up visit after 6 weeks and 2nd follow-up visit after 12 weeks. Outcome, was consideredfavourable if there was mild grade (IPSS <7) on 12th week after TRUP. Results: Total of 70 patients ofclinical BPH were included in study. Mean age of the patients was 63.1±3.0 yrs. Outcome oftransurethral resection of prostate was found to be favourable in 81.4% after 6 weeks in 1st follow-upvisit and in 62 (88.6%) patients after 12 weeks in second follow-up visit. Preoperatively mean IPSS was22.5 and postoperatively mean IPSS was 6.5. Conclusion: TURP is an effective and gold standardsurgical treatment option in the clinical BPH patients.Keywords: Benign prostatic hyperplasia, lower urinary tract, bladder outlet obstruction, acute urinaryretention, transurethral resection of prostate, TURP

References

Logan YT, Belgari MT. Monotherapy versus combination drug

therapy of the treatment of benign prostatic hyperplasia. Am J

Geriatr Pharmacother 2005;3:103–14.

McVary KT. BPH: Epidemiology and comorbidities. Am J

Manag Care 2006;12:122–8.

Rao CN, Singh MK, Shekhar T, Venugopal K, Prasad MR,

Saleem KI, et al. Causes of lower urinary tract symptoms

(LUTS) in adult Indian males. Indian J Urol 2004;20:95–100.

Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peter CA,

editors. Evaluation of the urologic patient: history, physical

examination and urinalysis. Campbell-Wash Urology. 9th ed.

Philedelphia: Saunders, 2007. p.81–110.

Crawford WD. Management of lower urinary tract symptoms

suggestive of benign prostatic hyperplasia: the central role of the

patient risk profile. BJU International 2005; 4:1–5.

Ather H. Benign prostatic obstruction (BPO) – treatment. Med

Today 2003;1:73–7.

Rashid GH, Kowalewski T, Oppeheimer P, Ooms A, Krieger JN.

Sweet RM. The virtual reality transurethral prostatic resection

trainer: Evaluation of discriminate validity. J Urol

;177:2283–6.

Zhao Z, Wang G, Na YQ. Changes of urinary symptoms after

transurethral resection of the prostate and it correlation with

clinical parameters. Zhonghua Wai Ke Za Zhi 2007;45:957–9.

Chalise PR, Agrawal CS. Changes in urinary symptoms and

quality of life in men with benign prostatic hyperplasia after

transurethral resection of prostate. Nepal Med Coll J 2007;9:255–8.

Tang J, Yang J. Etiopathogenesis of benign prostatic

Hyperplasia. Ind J Urol 2009;25:312–7.

Kok ET, Bohnen AM, Groneveld FP, Busschbach JJ, Blanker

MH, Bosch JL. Changes in disease specific and generic quality

of life related to changes in lower urinary tract symptoms: the

Krimpen study. Journal of Urology 2005;174:1005–8.

Glover L, Glannon K, McLoughlin J, Emberton M. Mens

experience of lower urinary tract symptoms: factors relating to

bother. Br J Urol Intern 2004;94:563–7.

Wein AJ, Kavoussi LR, Novick AC, Peters CA, editors.

Anatomy of the lower urinary tract and male Genetalia.

Campbell- walsh urology, 9th Edition Saunders, Elsevire:

Philadelphia USA; 2007. p.38–77.

Prasad VK, Hakkinen JT, Shiri RA, Ansari AA. Prevalence and

Determinants of Lower urinary tract symptoms among expatriate

male workers in Qatar. Indian J Urol 2006;27:31.

Peedikayil AV, Shyamkumar NK, Kekre N. Diagnosing bladder

outlet obstruction can we do away with pressure flow studies?.

Indian J Urol 2004;20:36–41.

Roehrborn CG. Currently available treatment guidelines for men

with Lower urinary tract symptoms. Br J Urol Intern 2008;18–23.

Wein AJ, Kavoussi LR, Novick AC, Peters CA, editors.

Evaluation of the Urologic patient: minimally invasive and

endoscopic management of Benign prostatic Hyperplasia.

Campbell walsh urology, 9th ed. Philadelphia: Saunders, 2007.p.

–44.

Wagrell L, Schelin S, Nordling J, Rihthoff J, Magnusson B,

Schain M, Larson T, Boyle E, et al. Feedback microwave

thermotherapy versus TURP for clinical BPH- a randomized

controlled multicenter study. Urology.2002 Aug; 60(2):292–9.

Harvey MH, Leese T, Lloyd D, Osborn DE. Antibiotic

prophylaxis and secondary hemorrhage following transurethral

resection of the prostate: a prospective trial. Br Urol

;58:450–2.

Downloads

Published

2010-12-01